Top 10 ASX Dividend Stocks for Sep 2026 Download Free Report

Company price
95.57 USD 3.59 ( 3.90%)
Last update at 2026-09-25T20:03:00Z
VOLUME
1026743
Market Cap
7455.36M
P/E
11.53

Momentum Score

…

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
91.03
Low
96.45
High
52 Week Price Range
30.08
Low
95.57
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Hinge Health operates a digital musculoskeletal care platform offering virtual physical therapy, wearable sensors, coaching and care-management software to employers, health plans and providers. Long-term growth may be driven by a large addressable MSK burden, employers' focus on cost reduction, expansion into payer and Medicare channels and product extensions that support recurring enterprise revenue, which appears positioned to appeal to investors seeking data-driven, outcomes-focused healthcare solutions.

Principal risks include ongoing unprofitability and cash burn, significant competition and execution risk in scaling payer adoption and reimbursement, customer concentration with employer contracts and data privacy/security exposure.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
91.98
Dividend Yield
-
Revenue TTM
720.06M
Revenue Per Share
9.13
Gross Profit TTM
608.75M
Debt / Equity
0.02
ROE
30.38%
Net Debt
-199.96M
ROCE
-141.50%
Diluted EPS TTM
8.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Income before tax -527.26M -11.26M -108.55M
Net income -528.26M -11.93M -108.14M
Selling general administrative 325.48M 62.39M 67.02M
Selling and marketing expenses 313.93M 165.14M 147.62M
Gross profit 469.30M 300.59M 194.18M
Reconciled depreciation 5.13M 5.95M 5.63M
Ebit -541.02M -24.43M -130.51M
Ebitda -535.89M -22.08M -128.39M
Depreciation and amortization 5.13M 2.35M 2.13M
Operating income -546.37M -31.91M -130.51M
Other operating expenses 1134.23M 422.31M 423.24M
Tax provision 1.00M 0.68M -0.41M
Income tax expense 1.00M 0.68M -0.41M
Total revenue 587.86M 390.40M 292.73M
Total operating expenses 1015.67M 332.50M 324.69M
Cost of revenue 118.56M 89.81M 98.55M
Total other income expense net 19.11M 20.65M 21.97M
Net income from continuing ops -528.26M -11.93M -108.14M
Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Total assets 744.76M 673.26M 622.53M
Intangible assets 2.51M 1.81M 2.19M
Other current assets 88.34M 63.51M 46.67M
Total liab 366.23M 256.56M 195.25M
Total stockholder equity 378.54M 416.70M 427.28M
Other current liab 57.33M 25.73M 30.85M
Capital stock 199.87M 851.27M 851.27M
Retained earnings -1051.00M -522.74M -510.80M
Good will 64.10M 61.61M 61.61M
Cash 208.00M 300.79M 234.95M
Total current liabilities 362.41M 249.30M 184.16M
Current deferred revenue 300.86M 217.63M 140.47M
Net debt -199.96M -289.71M -219.22M
Short term debt 4.22M 3.81M 4.64M
Short long term debt total 8.04M 11.07M 15.73M
Other stockholder equity 1229.68M 88.10M 86.75M
Total current assets 533.90M 583.45M 529.88M
Long term investments 113.17M 0.00M -
Short term investments 155.87M 165.79M 188.40M
Net receivables 66.06M 42.49M 46.56M
Inventory 15.64M 10.87M 13.29M
Accounts payable 57.33M - -
Accumulated other comprehensive income -0.02M 0.07M 0.06M
Non currrent assets other 13.73M 9.41M 6.38M
Non current assets total 210.86M 89.81M 92.65M
Capital lease obligations 8.04M 11.07M 15.73M
Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Investments -103.70M 18.31M 1.50M
Total cashflows from investing activities -113.76M 18.31M 1.50M
Net borrowings 4.93M 0.00M 0.00M
Total cash from financing activities -150.47M -2.20M -3.00M
Net income -528.26M -11.93M -108.14M
Change in cash -92.79M 65.11M -65.41M
Begin period cash flow 302.59M 237.47M 302.88M
End period cash flow 209.80M 302.59M 237.47M
Total cash from operating activities 171.44M 49.00M -63.91M
Issuance of capital stock 255.68M 0.00M 0.00M
Depreciation 5.49M 5.95M 5.63M
Other cashflows from investing activities -5.36M -2.73M -2.64M
Change to inventory -4.76M 0.61M 10.56M
Change to account receivables -26.63M -1.34M -23.13M
Sale purchase of stock -65.03M 0.00M 0.00M
Other cashflows from financing activities -350.64M -2.81M -3.00M
Capital expenditures 0.71M 3.77M 4.62M
Change in working capital -2.01M 13.50M 9.41M
Stock based compensation 643.01M 0.74M 1.65M
Other non cash items 53.16M 41.33M 28.02M
Free cash flow 170.73M 45.23M -68.52M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
HNGE
Hinge Health, Inc.
3.59
3.90%
95.57 11.53 32.79 10.35 22.21 10.09 73.84
VEEV
Veeva Systems Inc Class A
5.84
2.12%
280.68 43.49 29.59 12.48 5.79 10.39 33.41
PMCUF
Pro Medicus Limited
-
-%
114.56 64.90 90.91 49.11 38.05 65.12 83.47
TEM
Tempus AI, Inc. Class A Common Stock
2.77
3.37%
85.01 - - 8.68 25.39 8.33 -
MTHRY
M3 Inc
0.21
3.90%
5.59 31.84 26.25 0.05 4.60 0.04 0.12

Profile*

Hinge Health, Inc.

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

455 Market Street, San Francisco, CA, United States, 94105

415 726 2206

1437

Name Title Year Born
Mr. Gabriel Mecklenburg Co-Founder, CTO & Executive Chairman 1989
Mr. Daniel A. Perez Co-Founder, CEO & Director 1986
Mr. James Pursley President 1980
Mr. James W. Budge Chief Financial Officer 1967
Mr. Alexander Annison Chief Operating Officer NA
Bianca Buck Finance & Head of Investor Relations NA
Mr. David Wood General Counsel NA
Ms. Erin Wilson Senior Vice President of Sales & Strategy NA
Dr. Jeffrey Krauss M.D. Chief Medical Officer NA
Mr. Hassan Asghar Chief Information Security Officer NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…